KR
Khosla Rachna Directrice du Développement Commercial
Other F
Historial del iniciado Directivo Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the full record of transactions filed by Khosla Rachna, Directrice du Développement Commercial. Officer active across 1 company, notably AMGEN INC. Cumulatively, 39 filings have been published. Split: 0 buy · 5 sells. Total volume traded: €1.9m. Activity tracked since 5 November 2021. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Khosla Rachna Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 39 en total
▼ SVP, Business Development · Directivos · 11 ago 2026 · AMGEN INC 2000 títulos @ 412,567 US$ 0.0004% mcap 18.2% de su flujo Common Stock SEC:0000318154-26-000137:0
◇ SVP, Business Development · Directivos · 13 ago 2026 · AMGEN INC 1252 títulos @ 162,60 US$ 0.0001% mcap 4.5% de su flujo Common Stock SEC:0000318154-26-000137:1
▼ SVP, Business Development · Directivos · 13 ago 2026 · AMGEN INC 1252 títulos @ 416,4256 US$ 0.0002% mcap 11.5% de su flujo Common Stock SEC:0000318154-26-000137:2
● SVP, Business Development · Directivos · 2 may 2026 · AMGEN INC 117 títulos @ 329,82 US$ 0.0000% mcap 3.5% de su flujo Common Stock SEC:0000318154-26-000065:0
● SVP, Business Development · Directivos · 2 may 2026 · AMGEN INC 108 títulos @ 329,82 US$ 0.0000% mcap 3.2% de su flujo Common Stock SEC:0000318154-26-000065:1
● SVP, Business Development · Directivos · 16 mar 2026 · AMGEN INC 707 títulos @ 366,21 US$ 14.7% de su flujo Common Stock SEC:0000318154-26-000030:0
◆ SVP, Business Development · Directivos · 3 mar 2026 · AMGEN INC 1876 títulos 0Common Stock SEC:0000318154-26-000019:0
▼ SVP, Business Development · Directivos · 12 nov 2025 · AMGEN INC 890 títulos @ 336,2422 US$ 13.9% de su flujo Common Stock SEC:0000318154-25-000082:0
● SVP, Business Development · Directivos · 5 nov 2025 · AMGEN INC 226 títulos @ 296,70 US$ 3.6% de su flujo Common Stock SEC:0000318154-25-000076:0
▼ SVP, Business Development · Directivos · 5 jun 2025 · AMGEN INC 1500 títulos @ 289,68 US$ 28.8% de su flujo Common Stock SEC:0001127602-25-017018:0
◆ SVP, Business Development · Directivos · 6 may 2025 · AMGEN INC 610 títulos 0Common Stock SEC:0001127602-25-013784:0
● SVP, Business Development · Directivos · 2 may 2025 · AMGEN INC 110 títulos @ 283,78 US$ 2.9% de su flujo Common Stock SEC:0001127602-25-013531:0
● SVP, Business Development · Directivos · 2 may 2025 · AMGEN INC 104 títulos @ 283,78 US$ 2.8% de su flujo Common Stock SEC:0001127602-25-013531:1
● SVP, Business Development · Directivos · 30 abr 2025 · AMGEN INC 74 títulos @ 288,56 US$ 2.0% de su flujo Common Stock SEC:0001127602-25-013284:0
● SVP, Business Development · Directivos · 17 mar 2025 · AMGEN INC 489 títulos @ 313,71 US$ 15.0% de su flujo Common Stock SEC:0001127602-25-010058:0
◆ SVP, Business Development · Directivos · 3 mar 2025 · AMGEN INC 1403 títulos 0Common Stock SEC:0001127602-25-008426:0
● SVP, Business Development · Directivos · 5 nov 2024 · AMGEN INC 212 títulos @ 316,91 US$ 6.6% de su flujo Common Stock SEC:0001127602-24-026628:0
◆ SVP, Business Development · Directivos · 7 may 2024 · AMGEN INC 532 títulos 0Common Stock SEC:0001127602-24-014856:0
● SVP, Business Development · Directivos · 5 may 2024 · AMGEN INC 41 títulos @ 311,29 US$ 1.3% de su flujo Common Stock SEC:0001127602-24-014510:0
● SVP, Business Development · Directivos · 2 may 2024 · AMGEN INC 74 títulos @ 277,37 US$ 2.0% de su flujo Common Stock SEC:0001127602-24-014352:0
● SVP, Business Development · Directivos · 30 abr 2024 · AMGEN INC 48 títulos @ 276,38 US$ 1.3% de su flujo Common Stock SEC:0001127602-24-014027:0
● SVP, Business Development · Directivos · 18 mar 2024 · AMGEN INC 438 títulos @ 268,87 US$ 11.5% de su flujo Common Stock SEC:0001127602-24-010856:0
◆ SVP, Business Development · Directivos · 6 mar 2024 · AMGEN INC 1256 títulos 0Common Stock SEC:0001127602-24-009245:0
● SVP, Business Development · Directivos · 5 nov 2023 · AMGEN INC 173 títulos @ 269,86 US$ 4.7% de su flujo Common Stock SEC:0001127602-23-026977:0
● SVP, Business Development · Directivos · 5 nov 2023 · AMGEN INC 144 títulos @ 269,86 US$ 3.9% de su flujo Common Stock SEC:0001127602-23-026977:1
25 de 39 declaraciones
Ver más (14 restantes) About Khosla Rachna Khosla Rachna is Directrice du Développement Commercial and SVP, Business Development at AMGEN INC. She has 36 filings in total, and across the sampled recent filings, sales total 750067 EUR, with filings dated from 2021-11-09 to 2026-05-05; the stated transaction nature is Retenue fiscale.